BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal ...
Since its introduction around 1970, embedded-passive (EP) technology has been regarded as expensive, complex, and difficult to design and manufacture. For decades, the technology was used only by the ...
COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP) technology, is pleased to announce its participation and exhibition at the Heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results